Top 3D Bio Printers startups
There are 70 3D Bio Printers startups which include Aspect Biosystems, Allevi, Xlife sciences, BICO, VoxCell BioInnovation. Out of these, 38 startups are funded, with 17 having secured Series A+ funding. United States has the most number of companies in 3D Bio Printers (22), followed by China
(6), and then Canada (4).
Over the past 10 years, an average of 2 new companies have been launched annually. Notably, several of these startups have been founded by alumni of Massachusetts Institute of Technology, Columbia University and Cornell University.
Here is the list of top 3D Bio Printers Startups
Developer of bioprinting technology and tissue therapeutics for regenerative medicine. The company’s platform integrates bioprinting, computational design, therapeutic cells, and biomaterials. It develops implantable tissues to replace, repair, or supplement biological functions. The focus is on creating solutions for metabolic and endocrine diseases. The company also collaborates with other organizations.
Key facts about Aspect Biosystems
- Founded Year: 2013
- Location: Vancouver (Canada)
- Stage: Series B
- Total Funding till date: $139M
- Investors: Pangaea Ventures, Radical Ventures and 21 Others
- Latest Funding Round: Series B, Jan 08, 2025, $*****
- Tracxn Score: 67/100 What is this?
- Competitors Rank: 1 of 108 Competitors
2. Allevi
3D bioprinting solutions: bioprinters, bioinks, and software for tissue engineering. They provide simplified bioprinting with versatile desktop 3D bioprinters, diverse bioinks, and user-friendly software. Their technology empowers researchers to design and engineer 3D tissues for applications like regenerative medicine, drug discovery, and disease modeling. They offer tools for extrusion bioprinting, precision printing, and creating complex geometries. Their products include bioprinters, bioinks for various tissues (liver, heart, bone, etc.), and essential reagents. They support the scientific community with resources like bioprinting protocols, blogs, webinars, and application notes. They also have an online shop with products like nozzles, alginate, photoinitiators, and calcium chloride. They offer login access for software, services, and support. They are focused on advancing bioprinting and regenerative medicine.
Key facts about Allevi
- Founded Year: 2014
- Location: Philadelphia (United States)
- Stage: Acquired
- Total Funding till date: $2.33M
- Investors: Ben Franklin Technology Partners, 500 Global and 14 Others
- Latest Funding Round: Seed, Oct 30, 2019, $*****
- Tracxn Score: 59/100 What is this?
- Competitors Rank: 2 of 108 Competitors
Developer of drugs for multiple diseases. The company is developing therapeutics for multiple indications such as antibody therapy for obesity, nanovesicles therapy for arthritis, antibody therapy for acute lymphocytic leukemia among others. The platform also offers services such as 3D bioprinting and AI-based software for cancer diagnosis among others.
Key facts about Xlife sciences
- Founded Year: 2013
- Location: Zurich (Switzerland)
- Stage: Public
- Total Funding till date: $62.8M
- Latest Funding Round: Series C, Dec 03, 2020, $*****
- Tracxn Score: 58/100 What is this?
- Competitors Rank: 3 of 108 Competitors
4. BICO
Provider of technologies, products, and services for life sciences research purposes. By using robotics, artificial intelligence, computer science, and 3D bioprinting the company develops and markets innovative technologies and enables researchers to culture cells in 3D, perform high-throughput drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
Key facts about BICO
- Founded Year: 2016
- Location: Boston (United States)
- Stage: Public
- Investors: Fore C Investment, Europa and 1 Other
- Latest Funding Round: Post IPO, Jan 10, 2023, $*****
- Tracxn Score: 55/100 What is this?
- Competitors Rank: 4 of 108 Competitors
Manufacturer of 3D bioprinters. It develops 3D bio-printers and bio-inks for drug development and tissue engineering. Its technology uses lasers that crosslink liquid polymers and bio-inks. It applies to the manufacturing of biomimetic tissues that reduce the time and cost of drug testing.
Key facts about VoxCell BioInnovation
- Founded Year: 2020
- Location: Victoria (Canada)
- Stage: Series A
- Total Funding till date: $4.54M
- Investors: E-Fund, WUTIF Capital and 4 Others
- Latest Funding Round: Series A, Feb 28, 2025, $*****
- Tracxn Score: 53/100 What is this?
- Competitors Rank: 6 of 108 Competitors
